Kuhns, Lisa M. https://orcid.org/0000-0001-8294-7801
Karnik, Niranjan
Hotton, Anna
Muldoon, Abigail
Donenberg, Geri
Keglovitz, Kristin
McNulty, Moira
Schneider, John
Summersett-Williams, Faith
Garofalo, Robert
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA041071)
Article History
Received: 3 December 2019
Accepted: 2 January 2020
First Online: 8 January 2020
Ethics approval and consent to participate
: This protocol has been approved by the Institutional Review Boards of Ann & Robert H. Lurie Children’s Hospital of Chicago (IRB 2011–14600), Rush University (IRB 15040605-IRB01), University of Chicago, (IRB IRB15–1454) and the University of Illinois at Chicago (IRB#2016–0190) respectively, with a waiver of parental permission for participation of minors (aged 16–17). The IRB of Howard Brown Health deferred to the Lurie Children’s IRB for this protocol. Study participants complete an informed consent process prior to participation in research activities through a web portal with a waiver of written consent. This study is monitored by a Data Safety and Monitoring Board (DSMB), the composition of which may be obtained from the study principal investigator at the lead institution. No criteria for discontinuing or modifying the intervention or trial stopping rules were defined for this study.
: Not applicable.
: The authors declare that they have no competing interests.